Protective efficacy of an H5/H7 trivalent inactivated vaccine produced from Re-11, Re-12, and H7-Re2 strains against challenge with different H5 and H7 viruses in chickens
三价的使失去活性的疫苗从 Re-11, Re-12,和 H7-Re2 生产了的 H5/H7 的保护的功效在鸡与不同 H5 和 H7 病毒对挑战拉紧作者机构:State Key Laboratory of Veterinary BiotechnologyHarbin Veterinary Research InstituteChinese Academy of Agricultural SciencesHarbin 150069P.R.China Harbin Weike Biotechnology Development CompanyHarbin 150069P.R.China
出 版 物:《Journal of Integrative Agriculture》 (农业科学学报(英文版))
年 卷 期:2020年第19卷第9期
页 面:2294-2300页
核心收录:
学科分类:090603[农学-临床兽医学] 09[农学] 0906[农学-兽医学]
基 金:This work was supported by the National Key R&D Program of China(2016YFD0501602,2017YFD0500701,and 2016YFEO203200) the National Natural Science Foundation of China(3167131307) the China Agriculture Research System(CARS-41-G12) and Central Publicinterest Scientific Institution Basal Research Fund(1610302017001)
主 题:avian influenza H5/H7 trivalent vaccine Re-11 Re-12 and H7-Re2 strains protective efficacy
摘 要:We developed an H5/H7 trivalent inactivated vaccine by using Re-11, Re-12, and H7-Re2 vaccine seed viruses, which were generated by reverse genetics and derived their HA genes from A/duck/Guizhou/S4184/2017(H5N6) (DK/GZ/S4184/17) (a clade 2.***.4.4d virus), A/chicken/Liaoning/SD007/2017(H5N1) (CK/LN/SD007/17) (a clade 2.***.2.1d virus), and A/chicken/ Guangxi/SD098/2017(H7N9) (CK/GX/SD098/17), respectively. The protective efficacy of this novel vaccine and that of the recently used H5/H7 bivalent inactivated vaccine against different H5 and H7N9 viruses was evaluated in chickens. We found that the H5/H7 bivalent vaccine provided solid protection against the H7N9 virus CK/GX/SD098/17, but only 50–60% protection against different H5 viruses. In contrast, the novel H5/H7 trivalent vaccine provided complete protection against the H5 and H7 viruses tested. Our study underscores the importance of timely updating of vaccines for avian influenza control.